The results of the present study demonstrate that GSK690693 may block the phosphorylation of AKT and lead to the inhibition of cell metastasis and radioresistance via the regulation of ZEB1/E-cadherin levels in NPC cell lines. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.